SGRYSurgery Partners, Inc.

Nasdaq surgerypartners.com


$ 24.87 $ -0.09 (-0.36 %)    

Monday, 29-Apr-2024 11:18:44 EDT
QQQ $ 432.30 $ -0.85 (-0.2 %)
DIA $ 383.12 $ -0.07 (-0.02 %)
SPY $ 509.79 $ -0.47 (-0.09 %)
TLT $ 88.92 $ 0.26 (0.29 %)
GLD $ 215.92 $ -0.13 (-0.06 %)
$ 24.55
$ 24.96
$ 22.22 x 100
$ 0.00 x 0
$ 24.81 - $ 25.11
$ 22.05 - $ 45.79
605,061
na
3.08B
$ 2.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-26-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-01-2023 06-30-2023 10-Q
4 05-02-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-02-2022 06-30-2022 10-Q
8 05-03-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-03-2021 09-30-2021 10-Q
11 08-04-2021 06-30-2021 10-Q
12 05-05-2021 03-31-2021 10-Q
13 03-10-2021 12-31-2020 10-K
14 11-04-2020 09-30-2020 10-Q
15 08-05-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-13-2020 12-31-2019 10-K
18 11-06-2019 09-30-2019 10-Q
19 08-09-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 03-15-2019 12-31-2018 10-K
22 11-09-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-10-2018 03-31-2018 10-Q
25 03-16-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-09-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 03-10-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
31 08-10-2016 06-30-2016 10-Q
32 05-06-2016 03-31-2016 10-Q
33 03-11-2016 12-31-2015 10-K
34 11-13-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cantor-fitzgerald-reiterates-overweight-on-surgery-partners-maintains-43-price-target

Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $43 price ta...

 barclays-initiates-coverage-on-surgery-partners-with-equal-weight-rating-announces-price-target-of-35

Barclays analyst Andrew Mok initiates coverage on Surgery Partners (NASDAQ:SGRY) with a Equal-Weight rating and announces Pr...

 cantor-fitzgerald-reiterates-overweight-on-surgery-partners-maintains-43-price-target

Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $43 price ta...

 rbc-capital-reiterates-outperform-on-surgery-partners-maintains-49-price-target

RBC Capital analyst Ben Hendrix reiterates Surgery Partners (NASDAQ:SGRY) with a Outperform and maintains $49 price target.

 citigroup-maintains-buy-on-surgery-partners-lowers-price-target-to-42

Citigroup analyst Jason Cassorla maintains Surgery Partners (NASDAQ:SGRY) with a Buy and lowers the price target from $43 to...

 cantor-fitzgerald-maintains-overweight-on-surgery-partners-maintains-43-price-target

Cantor Fitzgerald analyst Sarah James maintains Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $43 price tar...

 why-freshpet-shares-are-trading-higher-by-around-15-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter...

 surgery-partners-posts-weak-sales-joins-kosmos-energy-moderna-and-other-big-stocks-moving-lower-on-monday

U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, I...

 surgery-partners-q4-adjusted-eps-044-beats-038-estimate-sales-73540m-miss-74140m-estimate

Surgery Partners (NASDAQ:SGRY) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.3...

 earnings-scheduled-for-february-26-2024

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on...

 jim-cramer-says-its-still-not-too-late-to-buy-this-energy-stock

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is taking a "hard pass" on Surgery Partners, Inc. (...

Core News & Articles

VRCA: 52% | Verrica Pharmaceuticals' Development and Commercialization Partner, Torii Pharmaceutical Co., Ltd., Announces P...

 surgery-partners-announces-proposed-secondary-offering-of-8m-shares-of-common-stock

The Selling Stockholders will receive all of the net proceeds from this Offering. No shares are being sold by the Company.

 mondaycom-to-rally-around-20-here-are-10-top-analyst-forecasts-for-tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 td-cowen-upgrades-surgery-partners-to-outperform-lowers-price-target-to-35

TD Cowen analyst Gary Taylor upgrades Surgery Partners (NASDAQ:SGRY) from Market Perform to Outperform and lowers the price ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION